Teva Pharmaceutical Industries Limited (TEVA) NYSE
30.08
-0.17(-0.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.08
-0.17(-0.56%)
Currency In USD
| Market Cap | 35.86B |
| Enterprise Value | 49.69B |
| P/E Ratio | 24.13 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 2 |
| Price/Book Ratio | 4.33 |
| Enterprise/Revenue | 2.8 |
| Enterprise/EBITDA | 15.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.08 |
| Operating Margin | 0.18 |
| Return On Assets | 0.03 |
| Return On Equity | 0.2 |
| Revenue | 17.26B |
| Revenue/Share | 15.1 |
| Gross Profit | 8.94B |
| EBITDA | 3.14B |
| Net Income | 1.41B |
| Diluted EPS | 1.2 |
| Total Cash | 3.56B |
| Total Cash/Share | 3.1 |
| Total Debt | 17.38B |
| Total Debt/Equity | 2.2 |
| Current Ratio | 1.04 |
| Book Value Per Share | 6.89 |
| 52-Week Change | 102.56 |
| 52-Week High | 37.35 |
| 52-Week Low | 12.47 |
| Moving Average 50 Days | 32.14 |
| Moving Average 200 Days | 24.38 |
| Average Volume | 8.96M |
| Shares Outstanding | 1.16B |
| % Held by Institutions | 59.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | July 01, 2004 |